OraSure Technologies Approves Stock Plan Amendment at Annual Meeting

Orasure Technologies ( (OSUR) ) just unveiled an announcement.

On May 14, 2025, OraSure Technologies, Inc. held its Annual Meeting of Stockholders, where an amendment to the 2000 Stock Award Plan was approved, increasing the number of shares authorized for grant by 6,000,000 shares. The meeting also included the election of three Class I Directors, the ratification of Grant Thornton LLP as the independent registered public accounting firm for 2025, and an advisory vote on executive compensation, reflecting key governance and operational decisions impacting the company’s future direction.

The most recent analyst rating on (OSUR) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Orasure Technologies stock, see the OSUR Stock Forecast page.

Spark’s Take on OSUR Stock

According to Spark, TipRanks’ AI Analyst, OSUR is a Neutral.

Orasure Technologies faces significant financial challenges with declining revenue and negative profitability, reflected in a lower overall score. While the balance sheet is strong, cash flow inefficiencies and weak technical indicators are concerning. The earnings call provides some optimism with strategic growth and innovation plans, but external risks remain. The overall sentiment is cautious with room for improvement.

To see Spark’s full report on OSUR stock, click here.

More about Orasure Technologies

OraSure Technologies, Inc. operates in the healthcare industry, focusing on the development and distribution of diagnostic and collection devices. The company is known for its innovative products that serve various market needs, including disease detection and drug testing.

Average Trading Volume: 751,502

Technical Sentiment Signal: Sell

Current Market Cap: $199.7M

Learn more about OSUR stock on TipRanks’ Stock Analysis page.